1st Quarter - Report
CELGENE CORPORATION for CELGENE CORPORATION
Firm
Client
Income
—
Expenses
$510,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
-H.R. 3673
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | Congressional Staff, Rep. Greenwood, 2001-2004 |
| RICHARD T GIRARDS | — |
Health Issues HCR
-oral oncology parity (H.R. 1801) -340(b) organization and ongoing implementation -Medicare Parts B&D -implementation of Affordable Care Act-speciality tiers related to pharmaceuticals -H.R. 3091 (MODDERN Cures Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | — |
| RICHARD T GIRARDS | — |
| PATRICK GLIHA New | — |
Copyright/Patent/Trademark CPT
-U.S. policy with respect to China, Canada, and other countries -Trans-Atlantic Trade and Investment Partnership -Trans-Pacific Partnership -Trade Promotion Authority-patent reform (H.R. 3309 and S. 1720)
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD T GIRARDS | — |
| PATRICK GLIHA New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.